Hims & Hers Health (HIMS) Depreciation & Amortization (CF) (2020 - 2026)

Hims & Hers Health has disclosed Depreciation & Amortization (CF) across 7 years of filings, most recently posting $22.0 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $22.0 million, up 165.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $56.1 million (up 172.06% YoY), and the FY2025 annual result was $54.5 million, up 218.95% from the prior year.
• Depreciation & Amortization (CF) came in at $22.0 million for Q1 2026 at Hims & Hers Health, up from $18.1 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $22.0 million in Q1 2026 to a low of $900000.0 in Q3 2022.
• The 5-year median for Depreciation & Amortization (CF) is $2.8 million (2024), against an average of $5.5 million.
• Peak annual rise in Depreciation & Amortization (CF) reached 341.88% in 2022, while the deepest fall reached 41.79% in 2022.
• Hims & Hers Health's Depreciation & Amortization (CF) stood at $2.0 million in 2022, then surged by 32.24% to $2.7 million in 2023, then jumped by 128.03% to $6.1 million in 2024, then surged by 198.5% to $18.1 million in 2025, then grew by 21.34% to $22.0 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $22.0 million (Q1 2026), $18.1 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.